chr19-11033512-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP2
The NM_003072.5(SMARCA4):c.3769G>C(p.Asp1257His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003072.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.3769G>C | p.Asp1257His | missense_variant | Exon 26 of 36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.3769G>C | p.Asp1257His | missense_variant | Exon 26 of 35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.3769G>C | p.Asp1257His | missense_variant | Exon 26 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.3769G>C | p.Asp1257His | missense_variant | Exon 26 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.3769G>C | p.Asp1257His | missense_variant | Exon 26 of 35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.3769G>C | p.Asp1257His | missense_variant | Exon 27 of 35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.3769G>C | p.Asp1257His | missense_variant | Exon 26 of 34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.3769G>C | p.Asp1257His | missense_variant | Exon 26 of 34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.3769G>C | p.Asp1257His | missense_variant | Exon 27 of 35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.3181G>C | p.Asp1061His | missense_variant | Exon 23 of 32 | ENSP00000496004.1 | ||||
SMARCA4 | ENST00000644963.1 | c.2413G>C | p.Asp805His | missense_variant | Exon 19 of 28 | ENSP00000495599.1 | ||||
SMARCA4 | ENST00000644065.1 | c.2494G>C | p.Asp832His | missense_variant | Exon 19 of 27 | ENSP00000493615.1 | ||||
SMARCA4 | ENST00000642350.1 | c.2254G>C | p.Asp752His | missense_variant | Exon 18 of 27 | ENSP00000495355.1 | ||||
SMARCA4 | ENST00000643857.1 | c.2122G>C | p.Asp708His | missense_variant | Exon 17 of 25 | ENSP00000494159.1 | ||||
SMARCA4 | ENST00000538456.4 | c.25G>C | p.Asp9His | missense_variant | Exon 1 of 8 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a SMARCA4-related disease. This sequence change replaces aspartic acid with histidine at codon 1257 of the SMARCA4 protein (p.Asp1257His). The aspartic acid residue is highly conserved and there is a moderate physicochemical difference between aspartic acid and histidine. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, this is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.D1257H variant (also known as c.3769G>C), located in coding exon 25 of the SMARCA4 gene, results from a G to C substitution at nucleotide position 3769. The aspartic acid at codon 1257 is replaced by histidine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Missense and in-frame variants in SMARCA4 are known to cause neurodevelopmental disorders; however, such associations with rhabdoid tumor predisposition syndrome including small cell carcinoma of the ovary-hypercalcemic type (SCCOHT) are exceedingly rare (Kosho T et al. Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):262-75; Jelinic P et al. Nat Genet. 2014 May;46(5):424-6). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at